Stonegate Investment Group, LLC Novartis Ag Transaction History

Stonegate Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$92.52 - $104.91 $2,868 - $3,252	-31 Reduced 1.25%	2,441 $246,000
Q1 2023 Apr 20, 2023	SELL	$80.03 - $92.81 $18,326 - $21,253	-229 Reduced 8.48%	2,472 $227,000
Q4 2022 Jan 24, 2023	SELL	$75.55 - $92.52 $31,126 - $38,118	-412 Reduced 13.23%	2,701 $0
Q3 2022 Oct 28, 2022	BUY	$74.61 - $87.26 $10,370 - $12,129	139 Added 4.67%	3,113 $237,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $239,466 - $278,812	2,974 New	2,974 $251,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonegate Investment Group, LLC with notifications on news.